Envoy Medical, Inc Warrant (COCHW) Financials

Envoy Medical, Inc Warrant (COCHW) reported diluted earnings per share of -$1.23 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Envoy Medical, Inc Warrant (COCHW) had EBITDA of -$22.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Envoy Medical, Inc Warrant (COCHW) recorded an outflow of $18.4M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Envoy Medical, Inc Warrant (COCHW) recorded an outflow of $18.2M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Envoy Medical, Inc Warrant (COCHW) had $8.6M in total assets as of fiscal year 2025, including both current and long-term assets.

Envoy Medical, Inc Warrant (COCHW) invested $179K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Envoy Medical, Inc Warrant (COCHW) invested $12.5M in research and development during fiscal year 2025.

Envoy Medical, Inc Warrant (COCHW) had 77M shares outstanding as of fiscal year 2025.

Envoy Medical, Inc Warrant (COCHW) had a current ratio of 0.54 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Envoy Medical, Inc Warrant (COCHW) had a return on assets of -277.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2025, Envoy Medical, Inc Warrant (COCHW) held $3.7M in cash, cash equivalents and investments, and reported an operating cash outflow of $18.2M over that year. Dividing the one by the other, the reported balance equals about 2 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Envoy Medical, Inc Warrant (COCHW) has negative shareholder equity of -$12.2M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Envoy Medical, Inc Warrant (COCHW) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Envoy Medical, Inc Warrant (COCHW) reported a net loss of $23.8M while operations used $18.2M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Envoy Medical, Inc Warrant (COCHW) reported an operating loss of $22.3M against $1.6M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.